Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-30

FDA Approved: TERIFLUNOMIDE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA has approved a generic version of teriflunomide for relapsing forms of multiple sclerosis, filed by Zydus Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (generic) (teriflunomide)

Snippet

ORIG AP for TERIFLUNOMIDE (TERIFLUNOMIDE)